Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

5.41
-0.0900-1.64%
Post-market: 5.430.0200+0.37%18:16 EDT
Volume:13.52M
Turnover:73.30M
Market Cap:2.18B
PE:-3.20
High:5.65
Open:5.35
Low:5.28
Close:5.50
Loading ...

Strategic Positioning and Operational Resilience Justify Buy Rating for Recursion Pharmaceuticals

TIPRANKS
·
08 Apr

Recursion Pharmaceuticals (NasdaqGS:RXRX) Sees 27% Weekly Drop After Leadership Changes

Simply Wall St.
·
07 Apr

Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market

Fortune
·
03 Apr

Recursion to Participate in Upcoming Investor Conference

GlobeNewswire
·
01 Apr

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today

Motley Fool
·
01 Apr

Why Recursion Pharmaceuticals Inc. (RXRX) Performed Worst On Tuesday?

Insider Monkey
·
26 Mar

Cathie Wood’s ARK Investment buys 161K shares of Recursion Pharmaceuticals today

TIPRANKS
·
21 Mar

Why Recursion Pharmaceuticals (RXRX) Dipped More Than Broader Market Today

Zacks
·
21 Mar

Recursion Pharmaceuticals (NasdaqGS:RXRX) Jumps 12% Following US$500M Equity Offering

Simply Wall St.
·
19 Mar

Why Recursion Pharmaceuticals (RXRX) Went Up on Monday?

Insider Monkey
·
18 Mar

Recursion Pharmaceuticals Strengthens Board with New Appointments

TIPRANKS
·
18 Mar

Press Release: Recursion Bolsters Board of Directors with Former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus and Mammoth Biosciences COO and CFO Elaine Sun

Dow Jones
·
18 Mar

Recursion Pharmaceuticals call volume above normal and directionally bullish

TIPRANKS
·
17 Mar

Why Recursion Pharmaceuticals Stock Is Sinking Today

Motley Fool
·
10 Mar

Stock Track | Recursion Pharmaceuticals Soars 5.13% on Optimism Around Upcoming Clinical Milestones

Stock Track
·
08 Mar

4 Things You Need to Know if You Buy Recursion Pharmaceuticals Stock Today

Motley Fool
·
07 Mar

Down Over 40%, Is Recursion Pharmaceuticals a Buy on the Dip?

Motley Fool
·
06 Mar

News Flash: Analysts Just Made A Sizeable Upgrade To Their Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Forecasts

Simply Wall St.
·
05 Mar

AI Biotech Stocks Shined, With Ginkgo Up 8%, Recursion And Absci Up 4%, Crispr Up 3%

Tiger Newspress
·
05 Mar

Analysts Offer Insights on Healthcare Companies: Ramsay Health Care (OtherRMSYF) and Recursion Pharmaceuticals (RXRX)

TIPRANKS
·
05 Mar